Silgard
human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
Papillomavirus Infections
Uterine Cervical Dysplasia
Condylomata Acuminata
Immunization
Date of authorisation:
Revision: 33
Last updated:
MedicineHumanWithdrawn
Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard - referral
bivalent HPV vaccine (types 16, 18)
quadrivalent HPV vaccine (types 6, 11, 16, 18)
9-valent HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52 and 58)
Article 20 procedures
Associated names:
Cervarix
Gardasil
Gardasil 9
Silgard
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
Protium - referral
pantoprazole
Article 30 referrals
Associated names:
Anagastra
Apton
Controloc
Eupantol
Inipomp
Pantec
Pantecta
Pantipp
Panto-Byk-20 / 40 / IV
Pantoc
Pantoloc
PantoLomberg
Pantopan
Pantorc
Pantozol
Peptazol
Rifun
Somac
Ulcotenal
Zurcal
Zurcale
Zurcazol
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
Human Papillomavirus1 Type 6 L1 protein / Human Papillomavirus1 Type 11 L1 protein / Human Papillomavirus1 Type 16 L1 protein / Human Papillomavirus1 Type 18 L1 protein - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Vaccines
PIP number: P/111/2009
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Suspension for injection in pre-filled syringe
Decision date:
Last updated:
Compliance check: ✖
PIPHuman